Skip to main content
ANAB
NASDAQ Life Sciences

Officer Dennis Mulroy Files to Sell Another $1.1M in Stock, Continuing Recent Liquidation Trend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$51.36
Mkt Cap
$1.495B
52W Low
$11.402
52W High
$72.36
52W Position info
350% above low
Off High info
29% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

Officer Dennis Mulroy has filed a Form 144 indicating intent to sell an additional $1.12 million worth of common stock, extending a recent pattern of significant insider sales.


Key Events · Ownership and Investor Activity · ANAB

  • Officer Files to Sell Shares

    Officer Dennis Mulroy has filed a Form 144 to sell 21,987 shares of common stock, valued at approximately $1.12 million.

  • Continuation of Selling Trend

    This filing extends a pattern of significant insider selling by Dennis Mulroy, who has reported over $9.98 million in sales over the past three months.

  • Context of Corporate Actions

    The ongoing insider sales occur after the company completed its biopharma spin-off and announced a $100 million share repurchase program in May.


Analysis · ANAB · Life Sciences

This Form 144 indicates an officer's intent to sell a significant block of shares, adding to a consistent pattern of insider selling by Dennis Mulroy over the past three months. While the company recently completed a major spin-off and initiated a share repurchase program, the continued liquidation of shares by an officer could be interpreted as a lack of conviction in the company's near-term prospects or a need for personal liquidity, potentially offsetting some positive sentiment from the buyback.

At the time of this filing, ANAB was trading at $51.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Jun 29, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.97
Real-time Price: $54.91 info
Change: -$11.06 (-17%) info
Market Cap: $1.626B info
ANAB
Jun 26, 2026, 4:46 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $63.15
Real-time Price: $54.91 info
Change: -$8.24 (-13%) info
Market Cap: $1.626B info
ANAB
Jun 22, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $59.32
Real-time Price: $54.91 info
Change: -$4.41 (-7%) info
Market Cap: $1.626B info
ANAB
Jun 17, 2026, 4:29 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $56.77
Real-time Price: $54.91 info
Change: -$1.86 (-3%) info
Market Cap: $1.626B info
ANAB
Jun 16, 2026, 5:28 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $57.60
Real-time Price: $54.91 info
Change: -$2.69 (-5%) info
Market Cap: $1.626B info